Published by If you or a loved one experienced side effects or health complications following the use of Lipodrene dietary supplements, you may be entitled to pursue compensation. At Schmidt & Clark, LLP, we are dedicated to helping individuals who have suffered due to dangerous supplements containing DMAA. Our experienced legal team is here to guide you through the process and fight for the compensation you deserve. Contact Schmidt & Clark, LLP today for a free, no-obligation consultation.
Table Of Contents
- Lipodrene Lawsuit Overview
- Latest Lipodrene Lawsuit Updates
- FDA Reports and Statistics
- What Is the FDA Doing to Remove DMAA Products from the Market?
- Lipodrene Injuries & Side Effects
- Do You Qualify for a Lipodrene Lawsuit?
- Lipodrene Recall Information
- Statute of Limitations for Lipodrene Lawsuits
- Frequently Asked Questions
- Take Action Now: Time-Sensitive Legal Claims
- References
Lipodrene Lawsuit Overview
Lipodrene lawsuits center on dietary supplements containing DMAA, which has been linked to serious cardiovascular problems. The primary allegations against manufacturers involve the inclusion of DMAA, a dangerous substance that can narrow blood vessels and arteries. The FDA has taken significant action against companies selling DMAA-containing products, including Hi-Tech Pharmaceuticals, the maker of Lipodrene.
Latest Lipodrene Lawsuit Updates
May 12, 2021 – Hi-Tech Pharmaceuticals initiated a voluntary recall of Lipodrene w/25mg Ephedra Extract Dietary Supplement Lot # 001211197, Exp. 12/25 after FDA analysis found the presence of DMAA in the product.
November 2020 – DMAA-containing products from Hi-Tech Pharmaceuticals were destroyed following court rulings that found DMAA is not generally recognized as safe.
2020 – The Supreme Court denied a request from Hi-Tech Pharmaceuticals to review their case regarding DMAA-containing products.
Related Article: DMAA Safety Issues Lawsuit
FDA Reports and Statistics
The FDA has warned about the dangers of DMAA in dietary supplements like Lipodrene:
“The FDA has warned that DMAA is dangerous because it can narrow blood vessels and arteries and cause a corresponding rise in blood pressure or other cardiovascular problems, such as Shortness of breath, Arrhythmias, Elevated blood pressure, Tightening in the chest, and Heart attack,” the agency said [1].
In 2013, the FDA took multiple enforcement actions:
- Seized DMAA-containing products from Hi-Tech Pharmaceuticals
- Detained OxyElite Pro and Jack3d products worth over $8 million at retail level
- Forced USPLabs to stop manufacturing with DMAA
In 2019, the U.S. Court of Appeals for the 11th Circuit affirmed that DMAA is not generally recognized as safe, condemning and forfeiting seized DMAA-containing products.
What Is the FDA Doing to Remove DMAA Products from the Market?
In recent years, the FDA has implemented a variety of methods to ensure DMAA-containing products are removed from the U.S. market. The agency is taking these actions to protect consumers and get these products off the shelves immediately.
Beginning in 2012, the FDA issued warning letters to companies notifying them that marketing DMAA-containing products was in violation of U.S. law. When the agency finds products containing DMAA during facility inspections, it gives them an opportunity to voluntarily recall and destroy the products. When firms have chosen not to comply voluntarily, the FDA has taken other actions.
In 2013, the FDA detained 2 DMAA-containing products, OxyElite Pro and Jack3d, after USPLabs refused to voluntarily comply. USPLabs was ultimately forced to destroy the detained products, which were worth over $8 million at the retail level, and agreed to stop manufacturing with DMAA.
Also in 2013, the FDA seized DMAA-containing products from Hi-Tech Pharmaceuticals; a federal district court ruled in April 2017 that the products were adulterated and ordered them condemned and forfeited to the United States for destruction.
In 2019, the U.S. Court of Appeals for the 11th Circuit affirmed the lower court ruling, finding that DMAA is not generally recognized as safe, and condemning and forfeiting the seized articles containing DMAA. The Supreme Court denied a request from Hi-Tech Pharmaceuticals to review the case in 2020. The products were destroyed in Nov. 2020.
Lipodrene Injuries & Side Effects
DMAA in Lipodrene has been associated with several serious cardiovascular side effects:
- Cardiovascular Problems: Narrowing of blood vessels and arteries
- Breathing Issues: Shortness of breath
- Heart Conditions: Arrhythmias, heart attack
- Blood Pressure: Elevated blood pressure
- Chest Discomfort: Tightening in the chest
Do You Qualify for a Lipodrene Lawsuit?
You may qualify for a Lipodrene lawsuit if:
- You used Lipodrene containing DMAA
- You experienced serious side effects including cardiovascular problems, breathing issues, or heart conditions
- The injuries required medical treatment or hospitalization
- You can provide medical documentation linking your injuries to Lipodrene use
Evidence Required for a Lipodrene Lawsuit
To strengthen your Lipodrene lawsuit case, you’ll need:
- Medical records documenting your injuries
- Proof of Lipodrene purchase or use
- Documentation of any communication with healthcare providers about your symptoms
Damages You Can Recover
In a successful Lipodrene lawsuit, you may be able to recover compensation for:
- Medical expenses related to treatment of side effects
- Lost wages due to inability to work
- Pain and suffering
- Ongoing healthcare costs
Lipodrene Recall Information
The recall affects Lot # 001211197, Exp. 12/25 of Lipodrene w/25mg Ephedra Extract Dietary Supplement. The supplements were purchased by and distributed through wholesale and direct sales in the U.S. and Puerto Rico, and through online sales for both personal use and retail sales.
If you purchased any dietary supplements that are affected by this recall, you should not take them, and either throw them away or return them to the point of purchase for a refund.
This recall began on May 12, 2021.
Statute of Limitations for Lipodrene Lawsuits
The statute of limitations for filing a Lipodrene lawsuit varies by state but generally ranges from one to three years from the date of injury or discovery of the injury. It’s important to consult with an attorney promptly to ensure your claim is filed within the legal timeframe.
Frequently Asked Questions
1. What is DMAA and why is it dangerous?
DMAA (dimethylamylamine) is a stimulant that can narrow blood vessels and arteries, causing increased blood pressure and cardiovascular problems. The FDA has warned that it can lead to shortness of breath, arrhythmias, chest tightening, and even heart attacks.
2. How long do I have to file a lawsuit after experiencing side effects from Lipodrene?
The statute of limitations varies by state but generally ranges from one to three years from the date of injury or discovery of the injury. It’s important to consult with an attorney promptly to ensure your claim is filed within the legal timeframe.
3. What should I do if I’ve been contacted by the manufacturer of Lipodrene after experiencing side effects?
If you’ve been contacted by the manufacturer, do not agree to any settlements or sign any documents without first consulting with an attorney. The manufacturer may attempt to settle the issue quickly and for less compensation than you may be entitled to.
4. How can I ensure my medical records accurately reflect the side effects I’ve experienced from Lipodrene?
Ensure that you provide your healthcare provider with detailed information about your use of Lipodrene and any symptoms you’ve experienced. Request that this information be thoroughly documented in your medical records, as it will be crucial for any legal action you pursue.
5. What are the FDA’s actions regarding harmful dietary supplements like Lipodrene?
The FDA can issue warnings, recalls, or bans on dietary supplements that are found to be harmful. They also monitor adverse event reports and can require manufacturers to make changes to product labeling or formulation. However, the FDA’s oversight is more limited compared to prescription drugs.
6. What should I do with Lipodrene products I still have at home?
If you have Lipodrene products affected by the recall (Lot # 001211197, Exp. 12/25), you should stop using them immediately and either return them to the point of purchase for a refund or discard them safely.
7. What compensation might I receive from a Lipodrene lawsuit?
Compensation may include medical expenses, lost wages, pain and suffering, and ongoing healthcare costs. The exact amount will depend on the severity of your injuries and their impact on your life.
Related Articles:
See all related dangerous drugs lawsuits our attorneys covered so far.
Take Action Now: Time-Sensitive Legal Claims
Time is limited to pursue legal action for Lipodrene-related injuries. Most states have a statute of limitations of only one to three years from the date of injury or discovery of injury.
At Schmidt & Clark, LLP, we offer:
- Free, confidential consultations to evaluate your case
- No upfront costs or fees for our services
- Payment only if we win your case
References
1. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hi-tech-pharmaceuticals-issues-voluntary-recall-lipodrene-w25mg-ephedra-extract-dietary-supplement